Merck KGaA (MRCG.DE)
26 May 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|58||2014||Chairman of the Supervisory Board|
|59||2016||Chairman of Executive Board and Chief Executive Officer|
|59||2014||Vice Chairman of the Supervisory Board, Employee Representative|
|2014||Member of the Executive Board, Chief Financial Officer|
|46||2016||CEO Life Science, Member of the Executive Board|
- Merck KGaA TV crystals sales decline raises stakes for cancer drug
- UPDATE 1-Merck KGaA TV crystals sales decline raises stakes for cancer drug
- BRIEF-Merck KGaA says losing some market share in liquid crystals to new Chinese rivals
- Merck KGaA Q1 earnings up on lab supplies, licence prepayment
- BRIEF-German Merck's Glucophage receives label extension in UK